Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February

Rhea-AI Summary

Lexeo Therapeutics (NASDAQ: LXEO) said members of management will present at two investor conferences in February 2026: a Guggenheim Emerging Outlook: Biotech Summit fireside chat on Feb 12, 2026 at 12:30 p.m. ET in New York and an Oppenheimer Healthcare Life Sciences fireside chat on Feb 26, 2026 at 10:40 a.m. ET (virtual).

Both events will be webcast live and replays will be available under the News & Events tab in the Investors section of the company website.

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that members of management will participate in the following investor conferences in February:

Guggenheim Emerging Outlook: Biotech Summit 2026. Fireside chat on Thursday, February 12, 2026 at 12:30 p.m. ET in New York, NY.

Oppenheimer 36^th Annual Healthcare Life Sciences Conference. Fireside chat on Thursday, February 26, 2026 at 10:40 a.m. ET (virtual).

The events will be webcast live under the News & Events tab in the Investors section of the Company’s website. A replay of the webcasts will be available on the Lexeo website following the presentations.

About Lexeo Therapeutics
Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular diseases are treated. The company is advancing a portfolio of therapeutic candidates that take aim at the underlying genetic causes of conditions, including LX2006 in Friedreich ataxia (FA) cardiomyopathy, LX2020 in plakophilin-2 (PKP2) arrhythmogenic cardiomyopathy, and others in devastating diseases with high unmet need.

Media Response:
Media@lexeotx.com

Investor Response:
Ashley Kaplowitz
akaplowitz@lexeotx.com

FAQ

When will Lexeo Therapeutics (LXEO) present at the Guggenheim Emerging Outlook: Biotech Summit in 2026?

Lexeo will present a fireside chat on Feb 12, 2026 at 12:30 p.m. ET. According to the company, management will appear in New York and the session will be webcast live via the Investors section under News & Events.

How can investors watch Lexeo Therapeutics (LXEO) at the Oppenheimer 36th Annual Healthcare Life Sciences Conference?

The Oppenheimer fireside chat is scheduled for Feb 26, 2026 at 10:40 a.m. ET and will be virtual. According to the company, the event will be webcast live and a replay will be posted on the Lexeo Investors website under News & Events.

Will Lexeo Therapeutics (LXEO) provide replays of the February 2026 investor presentations?

Yes. According to the company, replays of both February webcasts will be available on the Lexeo website after the live presentations. Investors can access them under the News & Events tab in the Investors section for on‑demand viewing.

What topics will Lexeo Therapeutics (LXEO) management likely cover during the February 2026 fireside chats?

Management will discuss corporate developments and the company’s clinical programs focused on cardiovascular genetic medicine. According to the company, presentations are intended for investor audiences and will be accessible via live webcast and subsequent replay on the investor site.

Where on the Lexeo Therapeutics (LXEO) site can investors find the live webcasts for the February 2026 conferences?

Live webcasts and replay files will be posted under the News & Events tab in the Investors section of the Lexeo website. According to the company, both the Feb 12 and Feb 26 sessions will be accessible there for live viewing and later replay.